BD 131975 - PowerLoc Max Safety Infusion Set, 19G x 0.75", Y-Site, 25/PK (Continental US Only)

BD 131975 - PowerLoc Max Safety Infusion Set, 19G x 0.75", Y-Site, 25/PK (Continental US Only)

The BD 131975 PowerLoc Max Safety Infusion Set is a sterile, power-injectable port-access device designed for accessing compatible surgically implanted vascular ports. The set features a 19-gauge non-coring needle with a 0.75-inch length, an integrated Y-injection site, and approximately 8-inch tubing for flexible connection during infusion therapy and vascular-access procedures.

The PowerLoc Max platform supports administration of compatible medications and fluids, blood specimen collection, implanted port flushing, and power injection through appropriately rated vascular-access systems. The 19-gauge configuration provides a larger fluid pathway suitable for applications requiring higher flow capability.

The 0.75-inch needle length is designed for implanted ports positioned relatively close to the skin surface. Proper needle-length selection helps support complete septum access, stable positioning, effective dressing application, and appropriate patient comfort.

The integrated Y-site provides an additional access point within the tubing for compatible intermittent medication administration, flushing, or connection of another approved fluid pathway. The exact BD 131975 configuration uses approximately 8-inch tubing and has an approximate priming volume of 0.4 mL.

The PowerLoc Max design incorporates a low-profile, wingless needle base with a non-absorbent padded footprint intended to support patient comfort and dressing management. A rotating needle hub allows clinicians to maneuver and position the tubing more conveniently around the access site.

An integrated single-step safety mechanism is housed within the plastic base. During deaccessing, the needle is withdrawn through the base, allowing the mechanism to cover the needle bevel and lock it into a protected position to help reduce accidental needlestick exposure.

BD 131975 corresponds to manufacturer catalog number 0131975 and is commercially supplied 25 sets per case.

Key Benefits

• 19-gauge non-coring needle supports access to compatible surgically implanted vascular ports.
• 0.75-inch needle length accommodates appropriately positioned superficial implanted ports.
• Larger 19-gauge fluid pathway supports applications requiring higher flow capability.
• Power-injectable design supports compatible contrast-enhanced diagnostic imaging procedures.
• Maximum power-injection flow rate up to 5 mL per second when the complete vascular-access system is appropriately rated.
• Integrated Y-injection site provides secondary access for compatible medication, flushing, or fluid administration.
• Approximately 8-inch tubing provides practical working length for implanted port-access procedures.
• Approximate 0.4 mL priming volume supports fluid-management planning.
• Luer-lock connection supports secure attachment to compatible infusion components.
• Non-coring needle design helps minimize unnecessary damage to compatible implanted port septa during appropriate access.
• Low-profile design supports dressing application and access-site management.
• Wingless configuration provides a compact footprint for site care.
• Non-absorbent padded base is designed to support patient comfort.
• Rotating needle hub assists with tubing positioning and dressing management.
• Clear base supports ongoing visibility and inspection of the access site.
• Dual-lumen port compatibility supports appropriate implanted port applications.
• Single-step safety mechanism covers and locks the needle bevel after deaccessing.
• Safety design helps reduce accidental needlestick exposure during removal, transport, and disposal.
• 25-per-case packaging supports routine hospital, oncology, infusion, and imaging inventory management.

Compatibility and Applications

The BD 131975 PowerLoc Max Safety Infusion Set is intended for use with compatible surgically implanted vascular-access ports designed to accept non-coring port-access needles.

Potential clinical applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood product administration, long-term infusion therapy, blood specimen collection, implanted port flushing, and compatible contrast-media injection during diagnostic imaging procedures.

The 19-gauge configuration may be selected when higher flow capability is required and the implanted port, prescribed therapy, and complete fluid pathway are compatible with a larger-gauge access needle. Selection should consider medication or fluid characteristics, required flow rate, implanted port specifications, infusion equipment, imaging requirements, and professional clinical judgment.

The 0.75-inch needle length is generally appropriate for implanted ports located relatively close to the skin surface. A needle that is too short may not completely access the port septum, while unnecessary additional needle length may affect stability, dressing placement, securement, and patient comfort.

The integrated Y-injection site provides secondary access within the tubing and may support compatible intermittent medication administration, flushing, or another approved fluid connection when permitted by the prescribed therapy and institutional protocol.

The PowerLoc Max platform is compatible with appropriate dual-lumen implanted port applications. Exact compatibility should be verified with the implanted port model, prescribed therapy, and facility procedures before use.

For power injection, the implanted port, PowerLoc Max needle, tubing, Y-site, connectors, extension components, and every other device within the complete fluid pathway must be appropriately rated for the intended procedure.

The lowest-rated component within the complete vascular-access system determines the actual maximum allowable pressure and flow rate, even though the 19-gauge PowerLoc Max configuration is rated for power injection up to 5 mL per second.

Usage Guidelines

The BD 131975 should be used only by healthcare professionals trained and authorized to access surgically implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and implanted port instructions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status when applicable.
• Assess the location and depth of the implanted port before selecting the 0.75-inch needle.
• Verify that the 19-gauge configuration is appropriate for the intended therapy or imaging procedure.
• Confirm that the integrated Y-site is appropriate for the planned clinical workflow.
• Inspect the sterile package for damage, punctures, moisture, contamination, or compromised integrity.
• Prepare the implanted port site using appropriate skin-antisepsis and sterile-access procedures.
• Prime the primary tubing and any intended secondary pathway completely with an approved solution.
• Remove air from the complete fluid pathway before accessing the implanted vascular port.
• Use the rotating hub to position the tubing appropriately for access and dressing placement.
• Stabilize the implanted port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate access to the port reservoir is achieved.
• Verify correct needle placement according to institutional policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and facility protocol.
• Secure the PowerLoc Max base and tubing to minimize pulling, twisting, pressure, or displacement.
• Apply an appropriate sterile dressing while maintaining access-site visibility.
• Disinfect the Y-injection site before every access according to institutional infection-prevention procedures.
• Maintain aseptic technique whenever connecting to or manipulating the Y-site.
• Monitor the access site for pain, swelling, redness, leakage, displacement, or other abnormalities throughout therapy.
• Confirm power-injection eligibility before connecting the system to a power injector.
• Do not exceed 5 mL per second or the lower operating limit of any component within the complete vascular-access system.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the implanted port while withdrawing the needle through the PowerLoc Max base.
• Confirm that the safety mechanism has covered and locked the needle bevel before further handling.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the vascular-access system if unexpected resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, displacement, or another abnormality develops at the implanted port site.

Certifications and Safety Standards

The BD 131975 PowerLoc Max Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The product is supplied sterile, and package integrity should be verified before use. A device should not be used if the sterile barrier is open, damaged, wet, contaminated, expired, or otherwise compromised.

The integrated safety mechanism is housed within the plastic needle base. During appropriate deaccessing, the needle is pulled through the base, allowing the mechanism to cover the needle bevel and lock it into a protected position.

This single-step safety design is intended to help reduce accidental needlestick injuries and potential exposure to bloodborne pathogens during needle removal, transport, and disposal.

The safety mechanism does not replace appropriate clinician training, personal protective equipment, safe sharps-handling practices, exposure-control procedures, or immediate disposal in an approved sharps container.

The non-coring needle should be selected according to patient anatomy, implanted port depth, prescribed therapy, required flow characteristics, and current manufacturer instructions.

Healthcare organizations should review current manufacturer documentation for applicable FDA status, UDI information, sterilization details, material composition, natural rubber latex information, DEHP information, shelf life, pressure limitations, warnings, precautions, contraindications, and other product-specific regulatory requirements.

Comparison with Competitors

Compared with conventional implanted port needles without integrated safety technology, the PowerLoc Max platform incorporates a single-step safety mechanism designed to cover and lock the needle bevel during deaccessing, helping reduce accidental sharps exposure.

Compared with PowerLoc Max configurations without a Y-injection site, BD 131975 provides an integrated secondary access point. This can support compatible intermittent medication administration, flushing, or another approved fluid pathway without disconnecting the primary line.

Compared with standard PowerLoc safety infusion sets, the PowerLoc Max platform features a compact wingless footprint, non-absorbent padded base, rotating hub, and low-profile design intended to support patient comfort and dressing management.

Compared with non-power-injectable port-access devices, BD 131975 supports compatible power-injection procedures at flow rates up to 5 mL per second when the implanted port and all other components within the complete system are appropriately rated.

Compared with 20-gauge PowerLoc Max configurations, the 19-gauge needle provides a larger fluid pathway, although compatible 19-gauge and 20-gauge PowerLoc Max configurations are both rated for power injection up to 5 mL per second.

Compared with 22-gauge PowerLoc Max configurations, the 19-gauge option supports greater maximum power-injection flow capability. Compatible 22-gauge configurations are rated for lower maximum flow.

Compared with 1-inch and 1.5-inch access needles, the 0.75-inch configuration provides a lower access profile for implanted ports positioned closer to the skin surface.

Alternative safety infusion sets may vary in gauge, needle length, tubing length, priming volume, Y-site availability, power-injection capability, safety activation method, base design, and packaging quantity. BD 131975 combines a 19-gauge, 0.75-inch non-coring needle with an integrated Y-site, approximately 8-inch tubing, 0.4 mL priming volume, padded wingless base, rotating hub, integrated safety lockout, and power-injection capability up to 5 mL per second.

Typical User Profile and Application Scenarios

The BD 131975 PowerLoc Max Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing surgically implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified healthcare personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, specialty practices, and other healthcare facilities where implanted vascular ports are routinely accessed.

The product may be selected for patients whose implanted port can be appropriately accessed with a 0.75-inch needle and whose prescribed therapy or diagnostic procedure is compatible with a 19-gauge access device.

Typical applications may include chemotherapy administration, antibiotic infusion, hydration, parenteral nutrition, blood product administration, blood specimen collection, implanted port flushing, routine port maintenance, and compatible contrast-enhanced imaging procedures.

The integrated Y-site is particularly useful in clinical workflows requiring secondary access for compatible intermittent medication administration, flushing, or connection of another approved fluid pathway.

Best Practices for Use and Maintenance

The BD 131975 is a sterile, single-use port-access device. Best practices focus on accurate product selection, sterile preparation, needle-length assessment, appropriate Y-site management, power-injection verification, access-site monitoring, safety activation, and disposal.

• Verify BD 131975 or manufacturer catalog number 0131975 before opening the package.
• Confirm the 19-gauge size, 0.75-inch needle length, and integrated Y-injection site configuration.
• Inspect package integrity and expiration information before use.
• Assess patient tissue depth and implanted port position before selecting the needle length.
• Confirm that the prescribed therapy and flow requirements are appropriate for a 19-gauge port-access device.
• Use strict aseptic technique throughout preparation, priming, insertion, connection, dressing, and deaccessing.
• Prime the complete primary and intended secondary fluid pathways before implanted port access.
• Consider the approximately 0.4 mL priming volume when precise fluid management is clinically important.
• Use the rotating hub to position tubing appropriately before securing the dressing.
• Maintain the padded base in a stable position to minimize unnecessary movement at the access site.
• Disinfect the Y-injection site according to institutional protocol before every access.
• Protect unused access points from contamination.
• Monitor the implanted port site and tubing connections throughout therapy.
• Verify that the complete vascular-access system is power injectable before any power-injection procedure.
• Do not exceed 5 mL per second or the lowest pressure or flow limitation of any component within the complete system.
• Do not bend, cut, modify, repair, or otherwise alter the infusion set.
• Do not reuse or reprocess a device intended for single use.
• Confirm complete safety lockout immediately following needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 131975 PowerLoc Max Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

BD identifies manufacturer catalog number 0131975 as the PowerLoc Max Power-Injectable Infusion Set with Y-Injection Site, 19G x 0.75-inch, with a maximum flow rate of 5 mL per second.

Before use, verify the product identity, 19-gauge size, 0.75-inch needle length, Y-site configuration, sterile package integrity, expiration date, and compatibility with the implanted vascular port.

The exact configuration includes approximately 8-inch tubing, a Luer-lock connector, low-profile hub, Y-site injection port, and approximately 0.4 mL priming volume.

The set should not be used for power injection unless the implanted port and every component within the complete fluid pathway are specifically rated for the intended procedure. Permitted pressure, flow rate, contrast-media characteristics, and other operating conditions must be confirmed before use.

The lowest-rated component within the complete vascular-access system determines the actual maximum allowable operating limit, even though the PowerLoc Max 19-gauge configuration is rated up to 5 mL per second.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may contribute to infiltration, extravasation, leakage, tissue injury, implanted port damage, interrupted therapy, or other complications.

The Y-injection site should be accessed only with compatible devices using appropriate disinfection and aseptic technique. Inadequate disinfection or improper manipulation may increase the risk of contamination, connection problems, or bloodstream infection.

The integrated safety mechanism should be fully engaged according to current manufacturer instructions after port deaccessing. The used device remains a contaminated sharp and should be discarded immediately in an approved sharps container.

BD lists manufacturer SKU 0131975 as 25 units per shelfpack with a minimum order quantity of one shelfpack, while commercial distributor listings identify the configuration as 25 per case. Purchasing personnel should confirm current availability, selling unit, storage requirements, and ordering information before procurement.

How to Order

Select the BD 131975 - PowerLoc Max Safety Infusion Set, 19G x 0.75", Y-Site and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.